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Infection with helminth parasites remains a persistent public health problem in developing
countries. Three of these pathogens, the liver flukes Clonorchis sinensis, Opisthorchis
viverrini and the blood fluke Schistosoma haematobium, are of particular concern due to
their classification as Group 1 carcinogens: infection with these worms is carcinogenic.
Using liquid chromatography-mass spectrometry (LC-MS/MS) approaches, we identified
steroid hormone like (e.g., oxysterol-like, catechol estrogen quinone-like, etc.) metabolites
and related DNA-adducts, apparently of parasite origin, in developmental stages including
eggs of S. haematobium, in urine of people with urogenital schistosomiasis, and in the
adult stage of O. viverrini. Since these kinds of sterol derivatives are metabolized to
active quinones that can modify DNA, which in other contexts can lead to breast and
other cancers, helminth parasite associated sterols might induce tumor-like phenotypes
in the target cells susceptible to helminth parasite associated cancers, i.e., urothelial
cells of the bladder in the case of urogenital schistosomiasis and the bile duct epithelia
or cholangiocytes, in the case of O. viverrini and C. sinensis. Indeed we postulate
that helminth induced cancers originate from parasite estrogen-host epithelial/urothelial
cell chromosomal DNA adducts, and here we review recent findings that support this
conjecture.
Keywords: urogenital schistosomiasis, opisthorchiasis, catechol-estrogens, oxysterols, DNA-adducts, neglected
tropical disease-associated-cancer, squamous cell carcinoma of the bladder, cholangiocarcinoma
BIOLOGICAL CARCINOGENS – THREE HELMINTH PARASITES
The World Health Organization’s International Agency for
Research on Cancer (IARC) and the United States’ National
Institutes of Health (NIH) consider that ∼20% of cancers are
caused by infectious diseases. Some cancer-inducing infectious
agents, such as Hepatitis B and C Viruses, are well known. How-
ever, less appreciated are the several major human helminth
pathogens that cause cancer. IARC recognizes three helminth
infections as definitive causes of cancer – the fish-borne liver
flukes Opisthorchis viverrini and Clonorchis sinensis and the blood
fluke Schistosoma haematobium (Bouvard et al., 2009; de Martel
et al., 2012; International Agency for Research on Cancer (IARC),
2012; Figure 1). In addition to direct detriment on develop-
ment and health of infected populations, infection with liver
flukes and schistosomes – types of helminth parasites collec-
tively termed trematode flatworms – lead to infection related
cancers, specifically cholangiocarcinoma (CCA; bile duct cancer)
and squamous cell carcinoma (SSC) of the urinary bladder,
respectively.
UROGENITAL SCHISTOSOMIASIS AND BLADDER CANCER
Three major species of schistosomes are the agents of human
schistosomiasis – Schistosoma japonicum and Schistosoma man-
soni cause intestinal schistosomiasis in East Asia, Africa, South
America, and the Caribbean while S. haematobium, occurring
widely throughAfrica and theMiddle East, causes urogenital schis-
tosomiasis (Figure 1). In the range of 4.5–70 million disability
adjusted life years (DALYs) are lost to schistosomiasis (King and
Dangerfield-Cha, 2008). More people are infected with S. haema-
tobium than with the other schistosomes. Of ∼112 million cases
of S. haematobium infection in sub-Saharan Africa, 70 million are
associated with hematuria, 18 million with major bladder wall
pathology, and 10 million with hydronephrosis leading to kid-
ney damage (van der Werf et al., 2003; Hotez et al., 2009; King,
2010). In many patients, deposition of S. haematobium parasite
ova eventually leads to SSC of the bladder (Hodder et al., 2000;
Parkin, 2006). Moreover, as many as 75% of women infected with
S. haematobium suffer from female genital schistosomiasis (FGS)
of the lower genital tract (Hotez et al., 2009). FGS results from
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FIGURE 1 | Geographical distribution of the carcinogenic flukes. Left:
Distribution of the blood fluke Schistosoma haematobium (sub-Saharan
Africa, Nile valley in Egypt and Sudan, the Maghreb, and the Arabian
peninsula). Right: Distribution of the liver flukes Clonorchis sinensis (China,
Republic of Korea, Democratic People’s Republic of Korea, the Russian
Federation, and northern Viet Nam) and Opisthorchis viverrini (Thailand, Laos,
Cambodia, Malaysia, and southern part of Viet Nam). “No local transmission”
stands for “no reported local transmission.” From International Agency for
Research on Cancer (IARC), (2012); permission requested fromWHO Press,
International Agency for Research on Cancer.
deposition of schistosome eggs in the uterus, cervix, vagina and
vulva, with ensuing inflammatory responses. It impairs fertility
(Santos et al., 2014) and also increases susceptibility of the woman
to HIV (Feldmeier et al., 1994; Kjetland et al., 2006; Ndhlovu et al.,
2007; Jourdan et al., 2011).
Squamous cell carcinoma is a malignant, poorly differentiated
neuroendocrine neoplasm. SCC is the common form of blad-
der cancer in rural Africa where S. haematobium is prevalent
(Mostafa et al., 1999; Zhong et al., 2013). In contrast, the major-
ity of bladder cancer in developing countries and regions not
endemic for urogenital schistosomiasis is transitional cell carci-
noma (TCC) that arises from the transitional epithelium lining
of the bladder. The parasite eggs trapped in the bladder wall
release antigens and other metabolites (presumably evolved to
expedite egress to the urine, and hence to the external envi-
ronment). Nonetheless, the phenomenon leads to hematuria
and to chronic inflammation, in turn increasing risk of urothe-
lial hyperplasia, dysplasia, and SCC of the bladder (Honeycutt
et al., 2014). The epidemiologic association between SSC of the
bladder with schistosomiasis haematobia is based both on case
control studies and on the correlation of bladder cancer inci-
dence with prevalence of infection with S. haematobium within
different geographic locations. Schistosomiasis haematobia is a
chronic infection, the adult, egg-producing schistosomes live for
many years, re-infections frequently occur, and schistosomiasis
associated bladder SCC appears relatively early, often by the mid-
decades of life. By contrast, TCC usually presents in the later
decades of life. The incidence of urogenital schistosomiasis asso-
ciated SCC is estimated in 3–4 cases per 100,000 (Shiff et al.,
2006).
FISH-BORNE FLUKES AND BILE DUCT CANCER
Liver infection caused by O. viverrini, C. sinensis and related flukes
remains a major public health problem in East Asia and East-
ern Europe where >40 million people are infected. O. viverrini
is endemic in Thailand, Lao PDR, Vietnam and Cambodia (Sripa
et al., 2011; Sithithaworn et al., 2012; Figure 1). Humans acquire
the infection with O. viverrini by eating undercooked, fresh water
cyprinoid fish infected with the metacercariae of the fluke (Sripa
et al., 2011). There the parasites mature over 6 weeks into adult
flukes, which graze on biliary epithelia. Eggs of O. viverrini are
shed in bile and exit the infected person with the fecal stream.
Freshwater snails ingest the eggs; the parasite (and related flukes,
above) undergoes transformations within the snail host, culmi-
nating in the release of cercariae that seek out and penetrate the
skin of a freshwater fish.Where sanitation is less than optimal, eggs
may enter fresh water ecosystems where the eggs are ingested by
freshwater snails. Human infection leads to hepatobiliary disease,
cholangitis, obstructive jaundice, hepatomegaly, periductal fibro-
sis, cholecystitis, and cholelithiasis (Blechacz et al., 2011; Mairiang
et al., 2012). More problematically, experimental and epidemio-
logical evidence implicates liver fluke in the etiology of a major
sub-type of liver cancer, CCA or bile duct cancer [Bouvard et al.,
2009; de Martel et al., 2012; International Agency for Research on
Cancer (IARC), 2012].
Cholangiocarcinoma, bile duct cancer, is an adenocarcinoma
of the bile ducts, with a dismal prognosis. These are slow
growing tumors, which spread along bile ducts with periductal
and mass forming extensions. Prognosis is poor owing to the
silent clinical character, difficulty in early diagnosis, and limited
therapeutic approaches, especially in resource poor settings such
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as northeastern Thailand where the recent estimate of median sur-
vival time after supportive treatment was 4 months (Thunyaharn
et al., 2013). Surgical management is the only potentially curative
treatment, but is restricted to early-stage disease. CCAhas aworld-
wide distribution, beyond East Asia, where patients often develop
CCA de novo without obvious risk factors. Primary sclerosing
cholangitis and congenital bile duct anomalies are also precursors.
In Thailand and elsewhere in East Asia, where infections with liver
flukes are definitive risk factor, the factors share a common deter-
minant of chronic inflammation and chronic injury of the biliary
epithelium, including from persistent parasitism by these fish-
borne trematodes (Sripa et al., 2009, 2012; Blechacz et al., 2011;
Johnson et al., 2012; O’Hara et al., 2013; Razumilava and Gores,
2013).
FLUKES, CATECHOL-ESTROGENS, OXYSTEROLS, AND
CARCINOGENESIS
In addition to the hormone-like effects of the parasite estradiol-
related molecules on the endocrine and immune system of the
host, initiation metabolites of estrogens can be also considered
as carcinogenic chemicals (Cavalieri and Rogan, 2011, 2014).
Hydroxylation of estrogens forms the 2- and 4-catechol estro-
gens involved in further oxidation to semiquinones and quinones,
including formation of the catechol estrogen-3, 4-quinones, the
major carcinogenic metabolites of estrogens. These electrophilic
compounds react with macromolecules, including DNA, to form
the depurinating adducts that eventually lead to mutations and
cancer initiation (Figure 2; Cavalieri and Rogan, 2011). Sev-
eral mechanisms explain the role of estrogens in disease. The
better-known hypothesis is that the estrogen receptor mediates
cell proliferation, increasing errors in DNA replication (Clemons
and Goss, 2001; Yager and Davidson, 2006; Botelho et al., 2009b,
2013). Another interpretation postulates that estrogen metabo-
lites react covalently with DNA bases by redox cycling or by
forming an abasic site. Subsequent error-prone repair of the
modified DNA generates oncogenic mutations that initiate can-
cer. The two mechanisms may act in concert. According to
the second mechanism, P450 metabolism of estrone and estra-
diol generates the catechol estrogens, 2-hydroxyestrogen and
4-hydroxyestrogen. Further oxidation leads to 2, 3-catechol-
FIGURE 2 | Carcinogenesis mediated by steroid hormone like molecules
derived from S. haematobium and O. viverrini. Eggs of S. haematobium
derived catechol-estrogens and DNA-adducts (left; Botelho et al., 2013), and
O. viverrini derived oxysterols (right; Vale et al., 2013), likely interact with the
chromosomes of target cells inducing DNA apurinic sites that eventually
escape the DNA repair mechanisms leading to mutations. These mutations
ultimately would transform the target cell, leading to hyperplasia and
ultimately to neoplasia, i.e., squamous cell carcinoma of the bladder [bottom
left, brief description adapted from Santos et al. (2014)] and liver fluke induced
cholangiocarcinoma (CCA; bottom right). Hematoxylin and eosin stained
section of human intrahepatic bile duct/liver, cholangiocarcinoma at bottom of
image (star) and an adult O. viverrini liver fluke (arrow) at top. Image
contributed by co-author Banchob Sripa. Human metaphase chromosomes –
image fromTang et al. (2013).
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estrogen quinine and 3, 4-catechol-estrogen quinone, respectively,
which can react directly with DNA via a Michael addition or indi-
rectly via generation of reactive oxygen species. Methylation of
catechol estrogens by catechol-O-methyltransferase, conjugation
of the catechol estrogen quinones with glutathione, and enzy-
matic reduction to reform catechol estrogens are processes that
prevent accumulation of the highly reactive metabolites. How-
ever, if the latter protective processes are insufficient, catechol
estrogen quinones accumulate, which damage DNA either by
oxidation or depurination, and release of catechol estrogen mod-
ified purines (Liehr et al., 1986; Cavalieri et al., 1997; Yager and
Davidson, 2006).
While examining human cases of urogenital schistosomia-
sis from Angola, we observed elevation in levels of estradiol in
sera but not luteinizing hormone (LH) or testosterone (Botelho
et al., 2009a). Estradiol is a steroid hormone secreted princi-
pally by the ovarian follicles in vertebrates. It seemed implausible
that the elevated levels could be attributed to hypothalamic–
pituitary–gonadal axis regulation. Rather, we speculated that
schistosomes produced the estradiol-related metabolites that con-
tributed to the elevated estradiol levels. Using mass spectrometry
approaches (Gouveia et al., 2013) we characterized >20 estradiol
related metabolites, from sera of S. haematobium-infected per-
sons from Angola and, remarkably, in the parasites including
the eggs (Botelho et al., 2013). Catechol-estrogens are formed by
hydroxylation on the steroid aromatic ring A. Hydroxylation of
both C-2 and C-3 on a steroid ring was apparent and, further,
oxidation to an estradiol-2,3-quinone. The schistosome estro-
genic metabolites readily seen in urine and in vitro appear to
arise by reactions of quinones of catechol estrogens with chro-
mosomal DNA (Botelho et al., 2011b, 2013). In addition, we
exposed non-cancerous CHO (Chinese hamster ovary) cells to
secretions and lysates of S. haematobium eggs and adult par-
asites, which stimulated cellular proliferation, migration and
invasion, inhibited apoptosis, up-regulated expression of Bcl-
2, and facilitated loss of p27 in CHO (Botelho et al., 2009a,b,
2010, 2011a,b, 2013) – processes that are hallmarks of tumori-
genesis and cancer cell survival (Hanahan and Weinberg, 2000).
If similar phenomena also occur in human urogenital schis-
tosomiasis, we speculate that they contribute to the abnormal
proliferation and accumulation of genetic changes that occur
in schistosomiasis-associated carcinogenesis [Figure 2; Mostafa
et al., 1999; International Agency for Research on Cancer (IARC),
2012].
Opisthorchiasis is associated with elevation of bile acids,
including deoxycholic acid (Vale et al., 2013) which are potent
tumor promoters in cholangiocarcinogenesis (Sirica, 2005). Bile
acids are synthesized in the liver from cholesterol, and the majori-
ties are conjugated with either glycine or taurine (Haswell-Elkins
et al., 1994; Ohshima et al., 1994; Akaike et al., 2003; Pinlaor et al.,
2003; Katsuma et al., 2005; Sirica, 2005; Yongvanit et al., 2012).
Inflammation-related carcinogenesis has also been associated
to oxidative and nitrative DNA damage as 8-oxo-7,8-hydro-2′-
deoxiguanine (8-oxodG) and 8-nitroguanine (8-NG; Yongvanit
et al., 2012). Increased levels of nitrate and nitrite, which reflect
endogenous generation of NO, occur during O. viverrini infection
in humans (Haswell-Elkins et al., 1994) and rodents (Ohshima
et al., 1994). Oxysterols, which are oxidation products of choles-
terol generated by enzymatic (P450) or non-enzymatic processes
(Jaworski et al., 2001; Jusakul et al., 2011), can be mutagenic or
genotoxic, and to possess pro-oxidative and pro-inflammation
properties that promote carcinogenesis. Investigation of binding
domains inhumangeneshas demonstrated an associationbetween
different types of oxysterols and the development and progression
of cancer of the colon, lung, breast and bile ducts (Jaworski et al.,
2001). Bile acids constitute a large family of steroids carrying a
carboxyl group in the side chain. Bile alcohols have similar prod-
ucts in bile acid biosynthesis or as end products. We found these
compounds in extracts of O. viverrini (Figure 2 compound 18)
but conjugated at different positions, free bile acids re-conjugated
in some species like aldehydes (Figure 2 compound 12) or as sul-
fates (not shown). The effects of these individual species can be
anticipated to be structure-dependent, and metabolic conversions
will result in a complex mixture of biologically active and inactive
forms (Vale et al., 2013).
INFECTION WITH BLOOD FLUKES AND LIVER FLUKES AS THE
RISK FACTOR – BUT HOW MIGHT CANCER ARISE?
Current understanding of how infections with these flukes lead to
cancers has been reviewed recently (Sithithaworn et al., 2012; Sripa
et al., 2012; Honeycutt et al., 2014). In brief, in regions of high
prevalence of opisthorchiasis, the risk factors for bile duct can-
cers are chronic inflammation and concomitant chronic injury of
the biliary epithelium as the consequence of persistent parasitism
by these fish-borne pathogens (Sripa et al., 2009, 2012; Blechacz
et al., 2011; Johnson et al., 2012; O’Hara et al., 2013; Razumilava
and Gores, 2013). The risk of SSC of the bladder during urogen-
ital schistosomiasis appears to be promoted by concurrent risk
factors associated with bladder cancer where infection with S.
haematobium is less commonor in non-endemic regions including
exposure to toxins such as dyes from industrial and agricultural
sources, and from tobacco smoke (see Honeycutt et al., 2014).
Thus there are likely to be multiple factors including a diet rich
in nitrosamines, spillover effects from local and systemic chronic
inflammation (reactive oxygen species, reactive nitrogen species)
directed against the worms, the secretion of mitogens and other
mediators by the parasite (Satarug et al., 1998; Sripa et al., 2012),
and interactions or changes in the biliary,GI tract andurinary tract
microbiota, including co-infection by other potentially oncogenic
biological species (Plieskatt et al., 2013).
To this list, we now include another potential mechanism:
lesions in chromosomes andproduction of depurinating estrogen-
DNA adducts leading to parasite metabolite-promoted host cell
DNA damage, due to parasite-derived, reactive oxysterol and/or
catechol estrogen derivatives. These processes contribute to uro-
genital schistosomiasis associated SCC during chronic urogenital
schistosomiasis, and to CCA during chronic opisthorchiasis
(Figure 2). Overall, the structures that we have identified in
S. haematobium and O. viverrini (Botelho et al., 2013; Vale
et al., 2013) suggest that carcinogenesis-related steroids may be
released in carcinogenic quantities by these flukes. Notably, a
relation between putative oxysterol or bile acid metabolites from
O. viverrini and bile duct cancer has long been hypothesized
(Changbumrung et al., 1990).
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CONCLUDING COMMENTS
Infection with helminth parasites remains a persistent public
health problem in developing countries. Three of these pathogens,
C. sinensis, O. viverrini, and S. haematobium, are of particu-
lar concern due to their classification by the IARC as Group 1
carcinogens. Infection with these worms is definitively associ-
ated with cancer. We have reported novel sterol-like metabolites
and DNA-adducts in S. haematobium, in urine of persons with
urogenital schistosomiasis, and in O. viverrini. Because these
molecules are metabolized to active quinones that can mod-
ify DNA, helminth parasite associated catechol estrogens might
induce tumor-like phenotypes in the epithelia of the bile ducts
and bladder. Whereas the roles of these new metabolites in bile
duct cancer and SSC of the bladder remain to be examined in
depth, this clearly is worthy of deeper investigation. Future studies
might profitably aim for isolation or chemical synthesis of these
putative carcinogens anddownstream investigation of interactions
of the fluke estrogens and oxysterols with informative cells such as
bladder urothelial cells (Botelho et al., 2013) and cholangiocytes
(Grubman et al., 1994), andwith oxysterol binding proteins and so
forth. The interrelations of these carcinogens and the microbiota
of the infected bladder and biliary system can also be predicted to
be informative (Plieskatt et al., 2013). Moreover, given that other
metabolites of O. viverrini are predicted to play a role in carcino-
genesis of O. viverrini induced bile duct cancer, including liver
fluke granulin (Smout et al., 2009), it will be informative also to
compare and contrast action of liver fluke granulin and other
fluke metabolites in these analyses, investigations that are now
facilitated by the availability of genome sequences of these carcino-
genic flukes (Wang et al., 2011; Young et al., 2012, 2014; Brindley
and Hotez, 2013; Huang et al., 2013), genome sequences of CCAs
(Chan-On et al., 2013), new rodent models (Fu et al., 2012),
and functional genomic approaches developed for these para-
sites (Rinaldi et al., 2011, 2012). In addition to their carcinogenic
effects, these flukes-associated sterol derivatives and DNA-adducts
could be exploited as diagnostic and prognostic biomarkers,
indeed 8-oxo dG in urine associates with opisthorchiasis-induced
CCA (Thanan et al., 2008), and as targets for novel interven-
tion strategies against these neglected tropical disease-associated
cancers.
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